Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Header cover image

Hong Kong Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

UPDATED Apr 24, 2024

High return on equity, past performance and sound balance sheet.

5 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	1681 Consun Pharmaceutical Group	HK$5.72	5.9%	14.9%	HK$4.5b	HK$7.87	PE5.4x	E14.4%	10.5%
	6600 SciClone Pharmaceuticals (Holdings)	HK$17.98	-0.3%	54.5%	HK$11.0b	HK$17.86	PE9x	E4.7%	0%
	9926 Akeso	HK$48.45	6.7%	12.4%	HK$41.1b	HK$59.75	PE19.1x	E12.2%	n/a
	3933 United Laboratories International Holdings	HK$9.77	2.1%	56.3%	HK$17.1b	HK$12.12	PE6.1x	E0.2%	5.8%
	690 Uni-Bio Science Group	HK$0.079	-12.2%	49.1%	HK$499.3m	n/a	PE6.9x	n/a	n/a

Page 1 of 1